ARIXTRA INJECTION 2.5mg/0.5ml syr (Fondaparinux Sodium)

ARIXTRA INJECTION (Fondaparinux Sodium) is a potent anticoagulant medication designed to prevent and treat blood clots. This injection is particularly beneficial for patients undergoing certain surgical procedures or those who are at risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Key highlights of ARIXTRA include:

• Mechanism of Action: Fondaparinux sodium works by selectively inhibiting factor Xa in the coagulation cascade, which helps to prevent the formation of blood clots.


• Indications: It is primarily indicated for the prevention of DVT following hip or knee surgery, as well as for the treatment of acute DVT and PE.


• Administration: The injection is given subcutaneously, usually once daily, providing ease of use for both healthcare providers and patients.


• Safety Profile: ARIXTRA is generally well-tolerated, with a lower risk of heparin-induced thrombocytopenia (HIT) compared to traditional heparin therapies.


• Monitoring: While routine monitoring of anticoagulation levels is not required, renal function should be assessed prior to therapy and periodically during treatment.


• Contraindications: It is contraindicated in patients with active bleeding, severe renal impairment, or those who have a history of hypersensitivity to the drug.


• Drug Interactions: Caution should be exercised when used in conjunction with other anticoagulants or antiplatelet agents, as this may increase the risk of bleeding.

Overall, ARIXTRA INJECTION offers an effective and convenient option for managing anticoagulation in patients at risk for thromboembolic events. Always consult a healthcare professional before starting treatment to ensure it is appropriate for your specific medical condition.

• Fondaparinux Sodium


• Water for Injection


• Sodium Chloride


• Hydrochloric Acid


• Sodium Hydroxide

ARIXTRA (Fondaparinux Sodium) injection is used to prevent and treat blood clots. It is important to follow the instructions carefully to ensure safe and effective use. Before starting the injection, wash your hands thoroughly with soap and water.

Gather all necessary supplies, including the ARIXTRA injection, alcohol swabs, and a sharps disposal container. Find a clean, well-lit area to administer the injection.

Choose an injection site, typically the fatty tissue of the abdomen or thigh, avoiding areas that are bruised, swollen, or scarred. Rotate injection sites to prevent irritation.

Clean the injection site with an alcohol swab and allow it to dry. Remove the ARIXTRA syringe from its packaging, ensuring you do not touch the needle. Hold the syringe like a pencil and remove the needle cover by pulling it straight off.

Pinch the skin around your chosen injection site to create a fold. Insert the needle into the fold at a 90-degree angle. Inject the medication slowly and steadily. Once the injection is complete, withdraw the needle quickly and apply gentle pressure to the site with a cotton ball or gauze.

Dispose of the needle and syringe in a sharps container immediately after use. Do not recap the needle. Monitor the injection site for any signs of bleeding or irritation. If you experience unusual symptoms or side effects, contact your healthcare provider promptly.

Keep ARIXTRA out of reach of children and store it at room temperature, away from light. Always follow your healthcare provider's specific instructions regarding dosage and frequency of injections.